Barinthus Biotherapeutics (BRNS) Other Working Capital Changes (2020 - 2026)
Barinthus Biotherapeutics (BRNS) reported Other Working Capital Changes of -$1.0 million for Q1 2026, down 277.62% on a YoY basis from $588906.5 in Q1 2025, and down 360.79% quarter-over-quarter from -$227000.0 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics has reported Other Working Capital Changes for 7 years, with the latest figure at -$1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 277.62% year-over-year to -$1.0 million; the trailing twelve-month figure through Mar 2026 stood at -$2.5 million (down 1194.76% YoY), and the FY2025 full-year result was -$1.7 million, up 4.75% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$1.0 million, down from -$227000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $2.7 million in Q2 2024, with the low at -$2.1 million in Q3 2024.
- Historically, Other Working Capital Changes has averaged -$251764.7 across 5 years, with a median of -$227000.0 in 2025.
- The largest YoY upside for Other Working Capital Changes was 18193.33% in 2024 against a maximum downside of 1424.39% in 2024.
- Barinthus Biotherapeutics' Other Working Capital Changes stood at $430000.0 in 2022, then sank by 146.74% to -$201000.0 in 2023, then slumped by 140.3% to -$483000.0 in 2024, then surged by 53.0% to -$227000.0 in 2025, then sank by 360.79% to -$1.0 million in 2026.
- The last three Other Working Capital Changes figures came in at -$1.0 million (Q1 2026), -$227000.0 (Q4 2025), and -$504000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.05 Mn |
| Mar 31, 2026 | -1.05 Mn |
| Dec 31, 2025 | -227,000.00 |
| Dec 31, 2025 | -227,000.00 |
| Sep 30, 2025 | -504,000.00 |
| Sep 30, 2025 | -504,000.00 |
| Jun 30, 2025 | -696,000.00 |
| Jun 30, 2025 | -696,000.00 |
| Mar 31, 2025 | -277,000.00 |
| Mar 31, 2025 | -277,000.00 |
| Dec 31, 2024 | -483,000.00 |
| Dec 31, 2024 | -483,000.00 |
| Sep 30, 2024 | -2.15 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | -1.88 Mn |
| Mar 31, 2024 | -1.88 Mn |
| Dec 31, 2023 | -201,000.00 |
| Dec 31, 2023 | -201,000.00 |